Pain — Study of Affect Induction for Lab Induced Pain in Healthy Undergraduates
Citation(s)
1 Sullivan MJL, Bishop SR, Pivik J. The Pain Catastrophizing Scale: Development and validation. Psychological Assessment. 2009;7(4):524-532. doi:10.1037/1040-3590.7.4.524
Curran S, Andrykowski M, Studts J Short Form of the Profile of Mood States (POMS-SF): Psychometric information. Psychological Assessment. Published online March 1995. Accessed January 11, 2020. https://www.academia.edu/1578109/Short_Form_of_the_Profile_of_Mood_States_POMS-SF_Psychometric_information
Darnall BD, Sturgeon JA, Kao MC, Hah JM, Mackey SC From Catastrophizing to Recovery: a pilot study of a single-session treatment for pain catastrophizing. J Pain Res. 2014 Apr 25;7:219-26. doi: 10.2147/JPR.S62329. eCollection 2014.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009 Apr;42(2):377-81. doi: 10.1016/j.jbi.2008.08.010. Epub 2008 Sep 30.
Rokke PD, al Absi M, Lall R, Oswald K When does a choice of coping strategies help? The interaction of choice and locus of control. J Behav Med. 1991 Oct;14(5):491-504. doi: 10.1007/BF00845106.
Tonelli ME, Wachholtz AB Meditation-based treatment yielding immediate relief for meditation-naive migraineurs. Pain Manag Nurs. 2014 Mar;15(1):36-40. doi: 10.1016/j.pmn.2012.04.002. Epub 2012 Jun 20.
Watson D, Clark LA, Tellegen A Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70. doi: 10.1037//0022-3514.54.6.1063.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
